Cargando…

Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease: in silico Molecular Docking Studies and in vitro Enzymatic Activity Assay

COVID-19 is an ongoing pandemic caused by the SARS-CoV-2 virus with important political, socio-economic, and public health consequences. Inhibiting replication represents an important antiviral approach, and in this context two viral proteases, the SARS-CoV-2 main and papain-like proteases (PL(pro))...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pitsillou, Eleni, Liang, Julia, Ververis, Katherine, Lim, Kah Wai, Hung, Andrew, Karagiannis, Tom C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753156/ https://www.ncbi.nlm.nih.gov/pubmed/33364229 http://dx.doi.org/10.3389/fchem.2020.623971

Ejemplares similares

Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay
por: Pitsillou, Eleni, et al.
Publicado: (2021)

Investigation of small molecule inhibitors of the SARS-CoV-2 papain-like protease by all-atom microsecond modelling, PELE Monte Carlo simulations, and in vitro activity inhibition
por: Liang, Julia J., et al.
Publicado: (2022)

Inhibition of interferon-stimulated gene 15 and lysine 48-linked ubiquitin binding to the SARS-CoV-2 papain-like protease by small molecules: In silico studies
por: Pitsillou, Eleni, et al.
Publicado: (2021)

Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay
por: Pitsillou, Eleni, et al.
Publicado: (2020)

Small molecule interactions with the SARS-CoV-2 main protease: In silico all-atom microsecond MD simulations, PELE Monte Carlo simulations, and determination of in vitro activity inhibition
por: Liang, Julia, et al.
Publicado: (2022)

Deubiquitinating Activity of the SARS-CoV Papain-Like Protease
por: Barretto, Naina, et al.
Publicado: (2006)

Nidovirus papain-like proteases: Multifunctional enzymes with protease, deubiquitinating and deISGylating activities
por: Mielech, Anna M., et al.
Publicado: (2014)

Decoupling deISGylating and deubiquitinating activities of the MERS virus papain-like protease
por: Clasman, Jozlyn R., et al.
Publicado: (2020)

The papain-like protease of avian infectious bronchitis virus has deubiquitinating activity
por: Yu, Liping, et al.
Publicado: (2017)

Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface
por: Liang, Julia, et al.
Publicado: (2020)

MERS-CoV papain-like protease has deISGylating and deubiquitinating activities
por: Mielech, Anna M., et al.
Publicado: (2014)

Interaction of the prototypical α-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: Molecular dynamic simulations highlight the stability of the ligand-protein complex
por: Liang, Julia, et al.
Publicado: (2020)

The SARS-CoV-2 helicase as a target for antiviral therapy: Identification of potential small molecule inhibitors by in silico modelling
por: Pitsillou, Eleni, et al.
Publicado: (2022)

Recognition of Lys48-Linked Di-ubiquitin and Deubiquitinating Activities of the SARS Coronavirus Papain-like Protease
por: Békés, Miklós, et al.
Publicado: (2016)

In silico investigation of potential small molecule inhibitors of the SARS-CoV-2 nsp10-nsp16 methyltransferase complex
por: Liang, Julia, et al.
Publicado: (2021)

Myricetin exerts its antiviral activity against infectious bronchitis virus by inhibiting the deubiquitinating activity of papain-like protease
por: Peng, Shuwei, et al.
Publicado: (2021)

In-silico docking studies of selected phytochemicals against papain like protease of SARS-Cov-2
por: Saranya, Palanisamy, et al.
Publicado: (2022)

The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity
por: Matthews, Krystal, et al.
Publicado: (2014)

Papain-like protease of SARS-CoV-2 inhibits RLR signaling in a deubiquitination-dependent and deubiquitination-independent manner
por: Ran, Xiang-Hong, et al.
Publicado: (2022)

In silico investigation to identify potential small molecule inhibitors of the RNA-dependent RNA polymerase (RdRp) nidovirus RdRp-associated nucleotidyltransferase domain
por: Pitsillou, Eleni, et al.
Publicado: (2021)

Role of T lymphocytes and papain enzymatic activity in the protection induced by the cysteine protease against Schistosoma mansoni in mice
por: Tallima, Hatem, et al.
Publicado: (2019)

Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro
por: Lewis, Devin S. M., et al.
Publicado: (2022)

Inhibitors of Deubiquitinating Enzymes Interfere with the SARS-CoV-2 Papain-like Protease and Block Virus Replication In Vitro
por: Große, Maximilian, et al.
Publicado: (2022)

In silico Exploration of Inhibitors for SARS-CoV-2's Papain-Like Protease
por: Huynh, Tien, et al.
Publicado: (2021)

Assay Systems for Profiling Deubiquitinating Activity
por: Cho, Jinhong, et al.
Publicado: (2020)

Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors
por: Li, Daoqun, et al.
Publicado: (2021)

Hepatitis E Virus Cysteine Protease Has Papain Like Properties Validated by in silico Modeling and Cell-Free Inhibition Assays
por: Saraswat, Shweta, et al.
Publicado: (2020)

In silico analysis of SARS-CoV-2 papain-like protease potential inhibitors
por: Elseginy, Samia A., et al.
Publicado: (2021)

SARS-CoV-2 Papain-Like Protease Potential Inhibitors—In Silico Quantitative Assessment
por: Stasiulewicz, Adam, et al.
Publicado: (2021)

Protocol for in vitro fluorescence assay of papain-like protease and cell-based immunofluorescence assay of coronavirus infection
por: Chang, JuOae, et al.
Publicado: (2023)

Supercomputing, Docking and Quantum Mechanics in Quest for Inhibitors of Papain-like Protease of SARS-CoV-2
por: Sulimov, A. V., et al.
Publicado: (2021)

THE REMOVAL OF CARTILAGE MATRIX, IN VIVO, BY PAPAIN : IDENTIFICATION OF CRYSTALLINE PAPAIN PROTEASE AS THE CAUSE OF THE PHENOMENON
por: McCluskey, Robert T., et al.
Publicado: (1958)

X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility for structure-based drug design
por: Clasman, Jozlyn R., et al.
Publicado: (2017)

Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV‑2 papain-like protease: Parthenolide covalently inhibits papain-like protease
por: Zou, Zhihui, et al.
Publicado: (2022)

Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking
por: Ibrahim, Tamer M., et al.
Publicado: (2020)

A Review of In Silico Research, SARS-CoV-2, and Neurodegeneration: Focus on Papain-Like Protease
por: Rieder, Alessandra S., et al.
Publicado: (2022)

Crystal structure of the Rubella virus protease reveals a unique papain-like protease fold
por: Cheong, Ezekiel Ze Ken, et al.
Publicado: (2022)

Proteases Underground: Analysis of the Maize Root Apoplast Identifies Organ Specific Papain-Like Cysteine Protease Activity
por: Schulze Hüynck, Jan, et al.
Publicado: (2019)

In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies
por: Alesawy, Mohamed S., et al.
Publicado: (2021)

Targeting multiple conformations of SARS-CoV2 Papain-Like Protease for drug repositioning: An in-silico study
por: Ismail, Muhammad I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jg8qu99p4iivbomn61ekjq1kri